Lupin Pharmaceuticals Inc. has recalled 4,113 cartons of Tydemy (drospirenone, ethinyl estradiol, and levomefolate calcium) tablets because testing showed the medication is subpotent. This means the drug may not contain the full required amount of its active ingredients, which can reduce its effectiveness in preventing pregnancy. No incidents or injuries have been reported to date.
Subpotent birth control medication may fail to prevent pregnancy as intended, leading to an increased risk of unintended pregnancy.
You have 2 options:
Rx Only. Distributed by Lupin Pharmaceuticals, Inc., Baltimore, Maryland. Manufactured by Lupin Limited, India.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.